About Spindle and kinetochore-associated protein 3
Spindle and kinetochore-associated protein 3 (SKA3) is a protein
from Homo sapiens identified by UniProt accession
Q8IX90, 412 residues long.
MolForge cross-references it against 0 known binders and
62 disease associations.
Target properties
| Protein name | Spindle and kinetochore-associated protein 3 |
| UniProt accession | Q8IX90 |
| Gene | SKA3 |
| Organism | Homo sapiens |
| Length | 412 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (62)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.39
- lysosomal storage disease · score 0.14
- hepatocellular carcinoma · score 0.11
- lung adenocarcinoma · score 0.10
- neoplasm · score 0.09
- urinary bladder carcinoma · score 0.09
- laryngeal squamous cell carcinoma · score 0.09
- breast cancer · score 0.08
- calf circumference measurement · score 0.08
- cholangiocarcinoma · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IX90-F1 | alphafold | PREDICTED | 63.82 | — |
Amino-acid sequence (412 residues)
MDPIRSFCGK LRSLASTLDC ETARLQRALD GEESDFEDYP MRILYDLHSE VQTLKDDVNI LLDKARLENQ EGIDFIKATK VLMEKNSMDI MKIREYFQKY GYSPRVKKNS VHEQEAINSD PELSNCENFQ KTDVKDDLSD PPVASSCISE KSPRSPQLSD FGLERYIVSQ VLPNPPQAVN NYKEEPVIVT PPTKQSLVKV LKTPKCALKM DDFECVTPKL EHFGISEYTM CLNEDYTMGL KNARNNKSEE AIDTESRLND NVFATPSPII QQLEKSDAEY TNSPLVPTFC TPGLKIPSTK NSIALVSTNY PLSKTNSSSN DLEVEDRTSL VLNSDTCFEN LTDPSSPTIS SYENLLRTPT PPEVTKIPED ILQLLSKYNS NLATPIAIKA VPPSKRFLKH GQNIRDVSNK EN
Explore Spindle and kinetochore-associated protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets